what’s happening
News & Events
Biodextris commissions a custom-designed cGMP biomanufacturing and analytical facility
We are proud to announce that Biodextris has commissioned a dedicated 30,000 sq.ft. custom-designed cGMP biomanufacturing facility including development and analytical capabilities to cater to growing demands. The bioprocessing building includes: 6,000 sq.ft....
Is cell culture to replace microbial fermentation?
Is cell culture to replace microbial fermentation in the biologics arena ? This question is certainly a common one for those looking at the industry overall and trying to decide where they want to invest their efforts. Traditionally microbial fermentation operations...
Why is process development such a lengthy activity?
Why is Process Development such a lengthy activity? Process development is a critical and lengthy activity, which holds a key place within discovery, development and manufacturing phases. Many clients reckon drug discovery is the lengthiest considering its pivotal and...
The importance of technical oversight (CMC) in drug development
The area of drug development is a veritable minefield with many junctures where a project can come to an abrupt end. The early discovery period presents its own significant challenges, but once a client has selected their lead candidate many organizations feel the...
How the Pandemic Supercharged Biodextris’ Business
The COVID-19 pandemic prompted an unprecedented influx of vaccine and therapeutic projects for Canadian biotech companies — and Biodextris is rising to the challenge. When pharmaceutical giant GSK restructured their Vaccine development to Belgium in 2015, the doors to...
Clean Biologics Acquires Biodextris
CLEAN BIOLOGICS ACQUIRES BIODEXTRIS: "We are excited to join forces with the Clean Biologics group and we look forward to introducing our shared client base to the advantages of this alliance." Read the Press Release here.